News | Peripheral Artery Disease (PAD) | October 12, 2016

Society for Vascular Surgery Announces New PAD Reporting Standards

Update of 1997 peripheral artery disease treatment standards reflects boom in endovascular devices and techniques

Society for Vascular Surgery, SVS, new PAD reporting standards, peripheral artery disease

October 12, 2016 — The Society for Vascular Surgery (SVS) has released new reporting standards focused on endovascular treatment of chronic lower extremity peripheral artery disease (PAD). Recommended reporting standards for lower extremity ischemia were last published by the SVS in 1997.

The last decade has seen a tremendous increase in the variety of endovascular devices and techniques to treat occlusive disease, the report authors state, and “the literature surrounding therapy for endovascular arterial disease consists of mixed-quality manuscripts without clear standardization.”

This document clarifies and updates the 1997 standards, specifically for reports on endovascular treatment. The document is divided into sections:

  • Claudication Reporting;
  • Critical Limb Ischemia Reporting;
  • Pre-intervention Assessment and Non-anatomic Treatment;
  • Intervention;
  • Outcome Measures – Procedural; and
  • Outcome Measures – Disease Specific and Complications.

The document provides a summary for reporting endovascular revascularization techniques in the setting of chronic disease, with much of it based on prior publications and SVS-proposed standards.

It also should:

  • Serve as a guide for the design of clinical trials; and
  • Be a reference for journal editors and reviewers when considering scientific work pertaining to endovascular therapy for chronic lower extremity arterial disease.

The abstract of the standards can be read here.

For more information: www.jvascsurg.org

Related Content

Lithotripsy Safe and Effective in Calcified Stenotic Peripheral Arteries
News | Peripheral Artery Disease (PAD) | December 04, 2018
New results from the DISRUPT PAD II study showed no perforations, embolization, reflow or abrupt closures with the...
Lutonix 014 Drug-Coated Balloon Safe and Effective Below the Knee
News | Peripheral Artery Disease (PAD) | November 07, 2018
The Lutonix Drug-Coated Balloon (DCB) showed statistically significant safety equivalence with a standard percutaneous...
Lokai Medical to Distribute NuCryo Vascular PolarCath Balloon Dilatation System in U.S.
News | Peripheral Artery Disease (PAD) | August 14, 2018
NuCryo Vascular announced that the company has signed a commercialization agreement with Lokai Medical, a specialty...
PQ Bypass Effective in Treating Extremely Long SFA Lesions at 12 Months
News | Peripheral Artery Disease (PAD) | July 02, 2018
The PQ Bypass Detour System showed promising 12-month durability for patients with extremely long blockages in the...
SCAI Releases Consensus Guidelines for Femoral-Popliteal Arterial Interventional Device Selection
News | Peripheral Artery Disease (PAD) | May 15, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to address the...
SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease
News | Peripheral Artery Disease (PAD) | May 14, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD Diagnosis and...
Critical Limb Ischemia Treatment Shows No Improvement at Three Months
News | Peripheral Artery Disease (PAD) | March 23, 2018
Patients with foot ulcers or gangrene who received the experimental drug JVS-100 did not show evidence of faster wound...
FDA Clears Corindus CorPath GRX for Peripheral Vascular Interventions
Technology | Peripheral Artery Disease (PAD) | February 20, 2018
Corindus Vascular Robotics Inc. announced today that it received 510(k) clearance from the U.S. Food and Drug...
News | Peripheral Artery Disease (PAD) | December 29, 2017
December 29, 2017 — iVascular announced the release of the new Oceanus 14 Pro percutaneous transluminal angioplasty (
Overlay Init